Bioventix (FRA:51B) Accounts Payable & Accrued Expense : €2.09 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bioventix Accounts Payable & Accrued Expense?

Bioventix's quarterly accounts payable & accrued expense declined from Dec. 2023 (€1.98 Mil) to Jun. 2024 (€1.60 Mil) but then increased from Jun. 2024 (€1.60 Mil) to Dec. 2024 (€2.09 Mil).

Bioventix's annual accounts payable & accrued expense declined from Jun. 2022 (€1.04 Mil) to Jun. 2023 (€1.01 Mil) but then increased from Jun. 2023 (€1.01 Mil) to Jun. 2024 (€1.60 Mil).

Bioventix Accounts Payable & Accrued Expense Historical Data

The historical data trend for Bioventix's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Accounts Payable & Accrued Expense Chart

Bioventix Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.49

0.85

1.04

1.01

1.60

Bioventix Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.41	1.01	1.98	1.60	2.09

Bioventix Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Bioventix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (FRA:51B) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BVXP:UK

Address

27–28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.bioventix.com

Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.

Bioventix Headlines

No Headlines